CSII - Cardiovascular Systems, Inc.
38.93 0.00 (0.00%)
After hours: 4:58PM EDT
| Previous Close | 39.64 |
| Open | 39.43 |
| Bid | 35.10 x 1100 |
| Ask | 40.79 x 900 |
| Day's Range | 37.55 - 39.69 |
| 52 Week Range | 24.84 - 42.64 |
| Volume | 158,119 |
| Avg. Volume | 534,808 |
| Market Cap | 1.356B |
| Beta (3Y Monthly) | 1.65 |
| PE Ratio (TTM) | 659.83 |
| EPS (TTM) | 0.06 |
| Earnings Date | Jul 29, 2019 - Aug 2, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 44.50 |
- Zacks•yesterday
ABIOMED Gets FDA Confirmation of the Safety of Impella RP
ABIOMED (ABMD) receives the FDA confirmation of the safety and effectiveness of the company's Impella RP heart pump.
- Zacks•3 days ago
Masimo Gets FDA Nod for Radius PPG, Boosts Patient Monitoring
Masimo (MASI) receives FDA 510 (k) clearance for Radius PPG, which is set to become an important breakthrough in patient monitoring.
- Zacks•3 days ago
Here's Why You Should Retain Cooper Companies (COO) Stock
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex volatility remains a concern.
- Zacks•7 days ago
Here's Why You Should Retain DaVita (DVA) in Your Portfolio
DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, divestment of DMG segment might lower cash flows.
- Zacks•9 days ago
Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now
PerkinElmer (PKI) is gaining steadily from its core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.
- Thomson Reuters StreetEvents•21 days ago
Edited Transcript of CSII earnings conference call or presentation 1-May-19 8:30pm GMT
Q3 2019 Cardiovascular Systems Inc Earnings Call
- Zacks•21 days ago
Cardiovascular Systems (CSII) Q3 Earnings Top, View Tapered
Cardiovascular Systems (CSII) rides high on a year-over-year rise in both Coronary and peripheral device revenues.
Motley Fool•22 days agoCardiovascular Systems Inc (CSII) Q3 2019 Earnings Call Transcript
CSII earnings call for the period ending March 31, 2019.
- Zacks•22 days ago
Cardiovascular Systems (CSII) Q3 Earnings and Revenues Top Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 150.00% and 0.82%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•22 days ago
Cardiovascular Systems: Fiscal 3Q Earnings Snapshot
The St. Paul, Minnesota-based company said it had net income of 2 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ...
- Business Wire•22 days ago
Cardiovascular Systems, Inc. Reports Fiscal 2019 Third-Quarter Financial Results
Conference Call Scheduled for Today, May 1, 2019, at 3:30 PM CT
- Simply Wall St.•28 days ago
Should We Be Cautious About Cardiovascular Systems, Inc.'s (NASDAQ:CSII) ROE Of 1.2%?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learning-by-doing, we'll look at ROE...
- Zacks•29 days ago
Analysts Estimate Cardiovascular Systems (CSII) to Report a Decline in Earnings: What to Look Out for
Cardiovascular Systems (CSII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Business Wire•last month
Cardiovascular Systems, Inc. to Webcast Fiscal 2019 Third-Quarter Earnings Conference Call Wednesday, May 1
Live Webcast at 3:30 p.m. CT
- Zacks•2 months ago
Cardiovascular Systems Gains on Global Growth & Innovation
Cardiovascular Systems (CSII) hopes that new product menu will deliver minimum 10% growth in its core business during the second half of fiscal 2019.
- Simply Wall St.•2 months ago
How Much is Cardiovascular Systems, Inc.’s (NASDAQ:CSII) CEO Getting Paid?
Scott Ward became the CEO of Cardiovascular Systems, Inc. (NASDAQ:CSII) in 2016. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth thatRead More...
- Business Wire•3 months ago
Cardiovascular Systems, Inc. to Present at Three Upcoming Investor Conferences
Cardiovascular Systems, Inc. , a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral
- PR Newswire•3 months ago
Washington Real Estate Investment Trust and Cardiovascular Systems Set to Join S&P SmallCap 600
NEW YORK , March 1, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Washington Real Estate Investment Trust (NYSE: WRE) will replace Investment Technology ...
- Zacks•3 months ago
Merit Medical (MMSI) Q4 Earnings & Revenues Surpass Estimates
Merit Medical (MMSI) registers solid expansion in adjusted gross margins in fourth-quarter 2018.
- Zacks•3 months ago
Veeva Systems (VEEV) Beats on Q4 Earnings and Revenues
Veeva Systems (VEEV) continues benefiting from its flagship Vault platform in fourth-quarter fiscal 2019.
- Zacks•3 months ago
Wright Medical (WMGI) Q4 Earnings & Revenues Beat Estimates
Wright Medical's (WMGI) top-line growth in fourth-quarter 2018 can be attributed to solid performance by the Upper and the Lower Extremities segments.
- Zacks•3 months ago
Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts
Bruker's (BRKR) CALID and NANO groups hold promise.
- Zacks•3 months ago
Here's Why Investors Should Buy DexCom (DXCM) Stock Now
Solid growth at the Sensor, Transmitter and Receiver segments provide DexCom (DXCM) a competitive edge in the MedTech space.
- Zacks•3 months ago
CVS Health Rides on Aetna Synergy, PBM Selling Season Modest
With regard to its 2019 PBM selling season, CVS Health (CVS) notes that the net benefits from this selling season are expected to be modest on Anthem-related headwinds.
- Zacks•3 months ago
Here's Why Investors Should Hold DaVita (DVA) Stock Now
DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.
